Authors


Jeff Goad, PharmD, MPH

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Michael Joyner, MD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Lauren M. Hynicka, PHARMD, BCPS, RYT-200

Latest:

And Then There Was One: HCV Elimination in the Coinfected Population

The evolution of treatment for hepatitis C virus during the past 15 years has been astounding, and we now are able to talk about how HCV could be eliminated.


Nabin K. Shrestha, MD, MPH

Latest:

Enhancing Outcomes in Outpatient Parenteral Antimicrobial Therapy

Nabin K. Shrestha, MD, MPH, evaluates the Cleveland Clinic's Outpatient Parenteral Antimicrobial Therapy (OPAT) program, revealing its effectiveness in managing infections while highlighting challenges in monitoring and the impact of infectious disease pharmacists on patient outcomes.


Sara Groome, PharmD, BCIDP

Latest:

Restoring Hope by Restoring Gut Flora: Rebyota and the Future of Combating Recurrent CDI

Although fecal microbiota, live-jslm (Rebyota; RBX2660) is the first fecal microbiota product approved by the FDA, there are other microbiota-based agents in the pipeline.


Eric John Burnett, MD

Latest:

The Roles of Misinformation, Disinformation, and Confirmation Bias in Public Health Discourse

Katrine Wallace, PhD, and Eric John Burnett, MD, discuss the distinctions between them and strategies to understand better the information people are consuming.


Angela Rasmussen, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Keith Lee

Latest:

Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.


Seth Lederman, MD

Latest:

Our Price for Not Aiming Higher: Long COVID Is Here to Stay

Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."



Paul Radspinner, MBA

Latest:

The Future of Influenza Vaccination: Insights from FluGen’s M2SR Vaccine Study

Paul Radspinner, MBA, president and CEO of FluGen, addresses the safety profile, noting the low adverse event rates highlighting the safety and tolerability of the H3N2 M2SR influenza vaccine.


Deborah (Debbi) Birx, MD

Latest:

Infection Control: AP Technology's Impact on Reducing HAIs and AMR Pathogens

Deborah Birx, MD, and Amy Carenza, BBA, highlight the targeting of multidrug-resistant organisms and tracking of infection trends without increasing staffing needs.


Marco Meglio

Latest:

COVID-19 Infection Does Not Impact Symptom Severity or Disability Trajectory in Multiple Sclerosis

Between those infected and uninfected with COVID-19, investigators observed no differences in symptom trajectories, assessed through SymptoMScreen.


Paul Tambyah, MD

Latest:

A Novel Approach to Infectious Disease Surveillance

The International Society for Infectious Diseases (ISID) ProMED surveillance system is a way for clinicians and interested ID stakeholders to be aware of local outbreaks and follow-up in response to get more information on them.


Tristan Timbrook PharmD, MBA, BCPS

Latest:

Lifting the Medical and Economic Burden of AMR in the US

This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.


Alwin M. Tilanus, MD

Latest:

Dose Optimization as a Strategy to Improve Clinical Outcomes and Suppress Antimicrobial Resistance

From the discovery of penicillin to PK-PD principles: A brief historical overview and what we have learned from recent clinical trials.


Laya Manoj

Latest:

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.


Randi Silibovsky, MD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Rebecca O’Toole

Latest:

Amoxicillin Treatment for Syphilis: Can an Old Drug Learn a New Trick?

With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.


Fidelia Bernice, PharmD, BCIDP

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Leanna Liu, PharmD, BCIDP, BCPS

Latest:

Amped-up Enterobacterales Debate

Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.


Mina Seo

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


Amy L. Brotherton, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Scott Bertani

Latest:

Mpox and Concerns Around the Disease in the United States

Scott Bertani, who is the director of Advocacy of the National Coalition for LGBTQ Health, discusses what the new mpox health declarations mean to the US, which groups are high risk, and information about the vaccine to prevent the disease.


Sarah B. Minor, PharmD, MHA, BCPS-AQ ID

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Noah Christian, MD

Latest:

RSV Prophylaxis: Palivizumab, Nirsevimab, and More

Current prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.


Chelsie Derman

Latest:

Hepatitis B Vaccination Increases Survival of Patients with Chronic Liver Disease

Hepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.


William R. Mikesell, PharmD

Latest:

No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections

At MAD-ID 2025, William R Mikesell, PharmD, presented data showing 20% vs 16% treatment failure rates in doxycycline and minocycline groups.


Rachel M. Kenney, PharmD

Latest:

Advancing C diff Management: Fidaxomicin, Microbiome Therapies, and Stewardship

At MAD-ID 2025, Rachel M. Kenney, PharmD, discusses treatment shifts, microbiome innovations, and pharmacists' roles in optimizing outcomes.

© 2025 MJH Life Sciences

All rights reserved.